CATALOGO DEI PRODOTTI DELLA RICERCA

SACERDOTI, David
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.708
EU - Europa 7.607
AS - Asia 7.593
SA - Sud America 1.002
Continente sconosciuto - Info sul continente non disponibili 453
AF - Africa 155
OC - Oceania 26
AN - Antartide 1
Totale 25.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.511
SG - Singapore 3.707
RU - Federazione Russa 3.523
CN - Cina 1.672
GB - Regno Unito 981
BR - Brasile 772
IT - Italia 713
VN - Vietnam 687
HK - Hong Kong 649
FR - Francia 609
IE - Irlanda 541
KR - Corea 293
DE - Germania 292
UA - Ucraina 282
SE - Svezia 250
FI - Finlandia 151
BD - Bangladesh 147
CA - Canada 101
ID - Indonesia 94
IN - India 90
AR - Argentina 87
NL - Olanda 54
EC - Ecuador 49
MX - Messico 47
AT - Austria 37
TR - Turchia 36
ES - Italia 35
JP - Giappone 34
ZA - Sudafrica 33
PL - Polonia 32
CO - Colombia 28
AU - Australia 25
IQ - Iraq 25
TG - Togo 22
CL - Cile 21
BE - Belgio 18
PH - Filippine 18
BJ - Benin 17
PK - Pakistan 17
NG - Nigeria 16
EG - Egitto 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
VE - Venezuela 12
PY - Paraguay 11
RO - Romania 11
LT - Lituania 10
DZ - Algeria 9
JO - Giordania 9
MA - Marocco 9
MY - Malesia 9
NP - Nepal 9
AZ - Azerbaigian 8
HN - Honduras 8
KE - Kenya 8
KZ - Kazakistan 8
SA - Arabia Saudita 8
AL - Albania 7
CZ - Repubblica Ceca 7
JM - Giamaica 7
CH - Svizzera 6
HU - Ungheria 6
IL - Israele 6
OM - Oman 6
TN - Tunisia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
NO - Norvegia 5
SC - Seychelles 5
CR - Costa Rica 4
GT - Guatemala 4
KW - Kuwait 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
BZ - Belize 3
DK - Danimarca 3
IR - Iran 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
Totale 25.054
Salva come PNG Salva come JPEG
Città #
Singapore 1.870
Ashburn 1.347
San Jose 1.053
Moscow 966
Southend 844
Jacksonville 791
Hong Kong 636
Dallas 591
Chandler 548
Dublin 539
Council Bluffs 513
The Dalles 455
Verona 375
Beijing 306
Lawrence 262
Princeton 262
Wilmington 221
Ho Chi Minh City 220
Los Angeles 170
Hanoi 139
Jinan 121
New York 112
Redondo Beach 111
Munich 105
Buffalo 103
Helsinki 103
Santa Clara 103
Shenyang 81
Ann Arbor 80
Dong Ket 79
São Paulo 74
Jakarta 63
Tianjin 61
Sindelfingen 59
Milan 56
Nanjing 52
Ningbo 51
Changsha 50
Orem 44
Haikou 41
Hebei 41
London 41
San Francisco 41
Seattle 41
Hangzhou 40
Houston 39
Columbus 38
Chennai 36
Guangzhou 36
Zhengzhou 34
Taizhou 32
Nuremberg 31
Tokyo 31
Brooklyn 30
Fairfield 30
Nanchang 30
Warsaw 29
Da Nang 28
Amsterdam 26
Frankfurt am Main 26
Phoenix 26
Boston 25
Chicago 25
Montreal 25
Rome 25
Taiyuan 25
Denver 24
Norwalk 24
Toronto 24
Redwood City 23
Rio de Janeiro 23
Turku 23
Lomé 22
Stockholm 22
Washington 22
Falkenstein 21
Haiphong 21
Lanzhou 21
Guayaquil 20
Johannesburg 19
Brussels 18
Mexico City 18
Cotonou 17
Lappeenranta 16
Vienna 16
Charlotte 15
Redmond 15
Atlanta 14
Brasília 14
Jiaxing 14
San Diego 14
Belo Horizonte 13
Biên Hòa 13
Curitiba 13
Manchester 13
Woodbridge 13
Abuja 12
Boardman 12
Fuzhou 12
Miami 12
Totale 15.081
Salva come PNG Salva come JPEG
Nome #
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 272
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 214
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 205
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 198
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 194
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 161
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 152
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 152
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 147
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 144
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 143
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 142
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 140
A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease 139
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 139
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 138
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 138
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia 137
Subclinical and clinical atherosclerosis in Non-alcoholic Fatty Liver Disease is associated with the presence of hypertension 135
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 135
Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial 131
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 130
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 130
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 128
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 128
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 127
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 127
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 126
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients 125
Alteration in endothelial function in cirrhosis 123
Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis 121
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 121
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 120
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 120
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 119
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 118
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 118
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 113
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 113
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 112
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study 111
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 111
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 111
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study 110
Alterazioni epatiche in corso di scompenso cardiaco 108
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 107
Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis 106
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 106
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 106
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 105
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 103
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 103
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 103
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 103
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 101
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 101
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 101
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 101
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 101
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 100
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 100
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 100
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 99
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 99
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 99
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 98
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis 98
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 97
Platelets in Non-alcoholic Fatty Liver Disease 96
Sistema vascolare epatico 95
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 95
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 95
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 94
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 94
Eicosanoid excretion in hepatic cirrhosis - Predominance of 20-HETE 94
A MULTICENTER CONTROLLED-STUDY COMPARING BETA-BLOCKERS AND BETA-BLOCKERS PLUS NITRODERIVATIVES IN THE PRIMARY PROPHYLAXIS OF 1ST VARICEAL BLEEDING IN CIRRHOSIS - INTERIM ANALYSIS 93
Author's Reply: “Bacterial infections predispose to the development of portal vein thrombosis in patients with decompensated cirrhosis” 93
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 93
Renal function in congestive heart failure. 93
Left ventricular diastolic function in liver cirrhosis 93
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 92
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 92
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 92
Drugs in the prevention of rebleeding in cirrhosis 92
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes 92
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler 92
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 92
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis 92
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 91
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 91
Early Diagnosis of Type-2 Cardio-renal Syndrome by Doppler Sonographic Evaluation of Renal Vasoconstriction 91
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 91
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 90
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 90
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 89
intrahepatic arterioportal fistulas in cirrhosis: usefulness of echo-Doppler as screening procedure 89
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 89
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery 89
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 89
Vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler. 88
Totale 11.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.536
article - articoli 85.807
book - libri 1.034
conference - conferenze 16.551
curatela - curatele 0
other - altro 556
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.588
Totale 217.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.494 0 209 11 23 111 21 54 116 108 116 238 487
2022/20232.483 283 156 347 236 379 701 15 101 162 10 49 44
2023/20241.224 52 86 86 113 70 198 129 77 2 63 251 97
2024/20254.564 298 280 183 803 163 51 110 480 523 244 361 1.068
2025/202612.458 1.149 687 692 1.848 2.728 880 1.327 976 906 604 241 420
2026/2027581 208 373 0 0 0 0 0 0 0 0 0 0
Totale 25.545